Medical research

To treat rare disease, NIH scientists repurpose FDA-approved drug

A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known ...

Genetics

Gene editing precisely repairs immune cells

Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus ...

Medical research

Drug cocktail holds promise for spinal injuries

The early-stage research in rats, by a group of scientists led by Imperial College London, revealed two existing medications can boost the body's own repair machinery, by triggering the release of stem cells from the bone ...

page 10 from 40